Established in 2008, Zhangjiang, Shanghai, Viva Biotech (Shanghai) Ltd. is a leading open-access and innovation-driven technology platform company which is dedicated to pre-clinic drug discovery. 

请拖入内容到容器
请拖入内容到容器
请拖入内容到容器
【R.S.V.P.】Viva Biotech 2021 Partnership Summit

【R.S.V.P.】Viva Biotech 2021 Partnership Summit

A Cradle for Promising Biotech Companies from around the World
Viva Biotech Awarded "Best Small and Medium Market Value Company"

Viva Biotech Awarded "Best Small and Medium Market Value Company"

The cradle for promising biotechnology startups all around the world.
QureBio’s Q-1802 Clinical Application Accepted by NMPA

QureBio’s Q-1802 Clinical Application Accepted by NMPA

The first Claudin 18.2/PD-L1 bispecific antibody drug accepted by NMPA.
Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform

Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform

Viva Biotech will give full play to its capabilities and advantages as a one-stop comprehensive service platform for drug R&D.
请拖入内容到容器